[The role of adrenergic mechanisms in the effects of some anti-tremor agents].
D000818:Animals; D001115:Arecoline / Q000037:antagonists & inhibitors; D004357:Drug Synergism; D005260:Female; D006016:Glycolates / Q000627:therapeutic use*; D006834:Hydrazines / Q000627:therapeutic use; D008297:Male; D051379:Mice; D009538:Nicotine / Q000037:antagonists & inhibitors; D010646:Phentolamine / Q000494:pharmacology / Q000627:therapeutic use*; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use*; D014050:Toluene / Q000627:therapeutic use; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy*; D014203:Tremorine / Q000037:antagonists & inhibitors; D014282:Trihexyphenidyl / Q000494:pharmacology / Q000627:therapeutic use*
D006016:Glycolates; D006834:Hydrazines; D014050:Toluene; D001115:Arecoline; D009538:Nicotine; D014282:Trihexyphenidyl; D011433:Propranolol; D014203:Tremorine; D010646:Phentolamine
O roli adrenergicheskikh mekhanizmov v deĭstvii nekotorykh protivotremornykh preparatov.